$JAZZ
Jazz Pharmaceuticals PLC Stock $jazz

$jazz Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-Q Financial Statement

#000123252421000061 Filed on November 09, 2021

Income Statement

Concept	2021 Q4	2021 Q3	2020 Q3
Revenue	$896.7M	$838.1M	$600.9M
YoY Change	34.74%	39.48%	11.75%
Cost Of Revenue	$136.2M	$145.2M	$42.10M
YoY Change	171.22%	244.95%	34.08%
Gross Profit	$760.6M	$692.9M	$554.9M
YoY Change	24.45%	24.88%	10.77%
Gross Profit Margin	84.82%	82.67%	92.34%
Selling, General & Admin	$254.9M	$363.7M	$207.3M
YoY Change	3.1%	75.48%	15.98%
% of Gross Profit	33.51%	52.49%	37.35%
Research & Development	$155.4M	$141.0M	$78.65M
YoY Change	21.73%	79.33%	-1.51%
% of Gross Profit	20.44%	20.35%	14.17%
Depreciation & Amortization	$164.6M	$167.6M	$71.50M
YoY Change	129.6%	134.37%	7.04%
% of Gross Profit	21.64%	24.19%	12.89%
Operating Expenses	$567.6M	$504.7M	$285.9M
YoY Change	28.44%	76.54%	10.57%
Operating Profit	$193.0M	$28.37M	$196.2M
YoY Change	14.02%	-85.54%	47.41%
Interest Expense	-$94.21M	-$93.37M	-$27.43M
YoY Change	229.41%	240.43%	53.56%
% of Operating Profit	-48.82%	-329.13%	-13.98%
Other Income/Expense, Net
YoY Change
Pretax Income	-$44.83M	-$67.63M	$168.1M
YoY Change	-130.96%	-140.22%	47.22%
Income Tax	-$12.47M	-$18.10M	$19.30M
% Of Pretax Income			11.48%
Net Earnings	-$35.35M	-$52.83M	$148.2M
YoY Change	-126.5%	-135.64%	44.94%
Net Earnings / Revenue	-3.94%	-6.3%	24.67%
Basic Earnings Per Share		-$0.86	$2.67
Diluted Earnings Per Share	-$574.6K	-$0.86	$2.64
COMMON SHARES
Basic Shares Outstanding	61.47M shares	61.28M shares	55.55M shares
Diluted Shares Outstanding		61.28M shares	56.24M shares

Balance Sheet

Concept	2021 Q4	2021 Q3	2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$591.4M	$671.8M	$1.917B
YoY Change	-72.27%	-64.95%	79.12%
Cash & Equivalents	$591.4M	$671.8M	$741.9M
Short-Term Investments	$80.70M	$130.0M	$1.511B
Other Short-Term Assets	$252.4M	$225.1M	$127.3M
YoY Change	65.51%	76.88%	56.33%
Inventory	$1.073B	$1.138B	$91.40M
Prepaid Expenses	$131.4M	$94.47M	$58.31M
Receivables	$563.4M	$499.0M	$361.7M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$2.611B	$2.628B	$2.556B
YoY Change	-8.04%	2.84%	68.07%
LONG-TERM ASSETS
Property, Plant & Equipment	$343.4M	$344.6M	$128.2M
YoY Change	168.44%	168.82%	-0.98%
Goodwill	$1.828B	$1.850B	$937.1M
YoY Change	90.71%	97.37%	3.35%
Intangibles	$7.152B	$7.283B	$2.241B
YoY Change	225.84%	224.95%	-13.57%
Long-Term Investments
YoY Change
Other Assets	$40.81M	$45.78M	$38.65M
YoY Change	58.68%	18.45%	-12.71%
Total Long-Term Assets	$9.687B	$9.850B	$3.736B
YoY Change	162.08%	163.62%	-6.76%
TOTAL ASSETS
Total Short-Term Assets	$2.611B	$2.628B	$2.556B
Total Long-Term Assets	$9.687B	$9.850B	$3.736B
Total Assets	$12.30B	$12.48B	$6.292B
YoY Change	88.17%	98.32%	13.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$100.3M	$63.82M	$67.06M
YoY Change	272.23%	-4.84%	-4.34%
Accrued Expenses	$666.3M	$603.7M	$302.1M
YoY Change	88.9%	99.86%	26.53%
Deferred Revenue	$2.093M	$2.267M	$3.090M
YoY Change	-17.79%	-26.63%	-34.53%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$31.00M	$31.00M	$244.0M
YoY Change	-87.41%	-87.3%	630.82%
Total Short-Term Liabilities	$809.3M	$735.1M	$642.1M
YoY Change	23.79%	14.47%	64.46%
LONG-TERM LIABILITIES
Long-Term Debt	$6.019B	$6.247B	$1.844B
YoY Change	225.61%	238.85%	17.37%
Other Long-Term Liabilities	$117.0M	$137.8M	$142.5M
YoY Change	15.67%	-3.28%	38.89%
Total Long-Term Liabilities	$6.136B	$6.385B	$1.986B
YoY Change	214.72%	221.48%	18.69%
TOTAL LIABILITIES
Total Short-Term Liabilities	$809.3M	$735.1M	$642.1M
Total Long-Term Liabilities	$6.136B	$6.385B	$1.986B
Total Liabilities	$6.945B	$7.120B	$2.628B
YoY Change	166.77%	170.9%	27.35%
SHAREHOLDERS EQUITY
Retained Earnings	$830.2M	$865.6M	$1.026B
YoY Change	-28.42%	-15.68%	-7.04%
Common Stock	$3.535B	$3.470B	$2.538B
YoY Change	34.22%	36.72%	14.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.965B	$3.938B	$3.377B
YoY Change
Total Liabilities & Shareholders Equity	$12.30B	$12.48B	$6.292B
YoY Change	88.17%	98.32%	13.82%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2020 Q3
OPERATING ACTIVITIES
Net Income	-$35.35M	-$52.83M	$148.2M
YoY Change	-126.5%	-135.64%	44.94%
Depreciation, Depletion And Amortization	$164.6M	$167.6M	$71.50M
YoY Change	129.6%	134.37%	7.04%
Cash From Operating Activities	$177.8M	$274.1M	$257.9M
YoY Change	-4.54%	6.27%	-23.59%
INVESTING ACTIVITIES
Capital Expenditures	-$9.967M	-$26.22M	-$13.30M
YoY Change	-75.21%	97.14%	-80.89%
Acquisitions
YoY Change
Other Investing Activities	-$125.0K	-$594.0K	-$266.3M
YoY Change	-100.11%	-99.78%	195.89%
Cash From Investing Activities	-$10.09M	-$26.81M	-$279.7M
YoY Change	-113.79%	-90.41%	75.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-246.6M	-465.2M	-22.70M
YoY Change	-541.16%	1949.26%	16.41%
NET CHANGE
Cash From Operating Activities	177.8M	274.1M	257.9M
Cash From Investing Activities	-10.09M	-26.81M	-279.7M
Cash From Financing Activities	-246.6M	-465.2M	-22.70M
Net Change In Cash	-78.95M	-217.9M	-44.50M
YoY Change	-125.04%	389.74%	-128.09%
FREE CASH FLOW
Cash From Operating Activities	$177.8M	$274.1M	$257.9M
Capital Expenditures	-$9.967M	-$26.22M	-$13.30M
Free Cash Flow	$187.7M	$300.3M	$271.2M
YoY Change	-17.08%	10.72%	-33.38%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001232524
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Registrant Name EntityRegistrantName	Jazz Pharmaceuticals plc
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2021Q3	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2020Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent
CY2021Q3	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent
CY2021Q3	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent
CY2020Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021Q3	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2020Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2021-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-33500
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	L2
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1032470
	dei	Entity Address Address Line1 EntityAddressAddressLine1	Fifth Floor, Waterloo Exchange,
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Waterloo Road
	dei	Entity Address City Or Town EntityAddressCityOrTown	Dublin 4
	dei	Entity Address Country EntityAddressCountry	IE
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	D04 E5W7
	dei	Country Region CountryRegion	353
	dei	City Area Code CityAreaCode	1
	dei	Local Phone Number LocalPhoneNumber	634-7800
	dei	Security12b Title Security12bTitle	Ordinary shares, nominal value $0.0001 per share
	dei	Trading Symbol TradingSymbol	JAZZ
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	61469645	shares
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	671780000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1057769000	USD
CY2021Q3	us-gaap	Investments Investments	0	USD
CY2020Q4	us-gaap	Investments Investments	1075000000	USD
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	499023000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	396490000	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	1137851000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	95396000	USD
CY2021Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	94474000	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	62422000	USD
CY2021Q3	us-gaap	Other Assets Current OtherAssetsCurrent	225098000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	152491000	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	2628226000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	2839568000	USD
CY2021Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	255006000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	127935000	USD
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	89628000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	129169000	USD
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7282579000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2195051000	USD
CY2021Q3	us-gaap	Goodwill Goodwill	1849547000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	958303000	USD
CY2021Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	314666000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	254916000	USD
CY2021Q3	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	12724000	USD
CY2020Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	5238000	USD
CY2021Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	45776000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	25721000	USD
CY2021Q3	us-gaap	Assets Assets	12478152000	USD
CY2020Q4	us-gaap	Assets Assets	6535901000	USD
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	63815000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	26945000	USD
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	603715000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	352732000	USD
CY2021Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	31000000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	246322000	USD
CY2021Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	34256000	USD
CY2020Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	25200000	USD
CY2021Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2267000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2546000	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	735053000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	653745000	USD
CY2021Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	986000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2315000	USD
CY2021Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	6247287000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1848516000	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	89359000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	140035000	USD
CY2021Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1329184000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	130397000	USD
CY2021Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	137806000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	101148000	USD
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	6000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	6000	USD
CY2021Q3	jazz	Nonvoting Euro Deferred Shares NonvotingEuroDeferredShares	55000	USD
CY2020Q4	jazz	Nonvoting Euro Deferred Shares NonvotingEuroDeferredShares	55000	USD
CY2021Q3	jazz	Capital Redemption Reserve CapitalRedemptionReserve	472000	USD
CY2020Q4	jazz	Capital Redemption Reserve CapitalRedemptionReserve	472000	USD
CY2021Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	3469884000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2633670000	USD
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-397517000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-134352000	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	865577000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1159894000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	3938477000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	3659745000	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12478152000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6535901000	USD
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	838115000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	600888000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2197507000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1698050000	USD
CY2021Q3	jazz	Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment	145224000	USD
CY2020Q3	jazz	Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment	42095000	USD
	jazz	Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment	304607000	USD
	jazz	Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment	98760000	USD
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	363682000	USD
CY2020Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	207255000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1053221000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	607061000	USD
CY2021Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	141036000	USD
CY2020Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	78647000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	350305000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	243676000	USD
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	159804000	USD
CY2020Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	66684000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	368476000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	192505000	USD
CY2021Q3	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	0	USD
CY2020Q3	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	10000000	USD
	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	0	USD
	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	215250000	USD
CY2021Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2020Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	136139000	USD
CY2021Q3	us-gaap	Costs And Expenses CostsAndExpenses	809746000	USD
CY2020Q3	us-gaap	Costs And Expenses CostsAndExpenses	404681000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	2076609000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	1493391000	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	28369000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	196207000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	120898000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	204659000	USD
CY2021Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-93372000	USD
CY2020Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-27428000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-190168000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-72134000	USD
CY2021Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2631000	USD
CY2020Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-639000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1262000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2235000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-67634000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	168140000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-68008000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	130290000	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-18057000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	19283000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	228583000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	22750000	USD
CY2021Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3256000	USD
CY2020Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-623000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2274000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2338000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-52833000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	148234000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-294317000	USD
	us-gaap	Net Income Loss NetIncomeLoss	105202000	USD
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.86
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.67
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.98
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.89
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.86
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.64
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.98
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.87
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61284000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55545000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59084000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55637000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61284000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56236000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59084000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56297000	shares
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-52833000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	148234000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-294317000	USD
	us-gaap	Net Income Loss NetIncomeLoss	105202000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-206819000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	47139000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-265342000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	37879000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	22000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	167000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	353000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	-327000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	153000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	1169000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	2468000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-2287000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Financial Liability Fair Value Option After Reclassification Adjustment Tax OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterReclassificationAdjustmentTax	28000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Financial Liability Fair Value Option After Reclassification Adjustment Tax OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterReclassificationAdjustmentTax	0	USD
	us-gaap	Other Comprehensive Income Loss Financial Liability Fair Value Option After Reclassification Adjustment Tax OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterReclassificationAdjustmentTax	-97000	USD
	us-gaap	Other Comprehensive Income Loss Financial Liability Fair Value Option After Reclassification Adjustment Tax OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterReclassificationAdjustmentTax	0	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments Tax OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsTax	-84000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments Tax OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsTax	0	USD
	us-gaap	Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments Tax OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsTax	291000	USD
	us-gaap	Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments Tax OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsTax	0	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-206582000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	48308000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-263165000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	35592000	USD
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-259415000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	196542000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-557482000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	140794000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	3659745000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	50407000	USD
CY2021Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	23784000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	34565000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-45076000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	121832000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	3797689000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	608456000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	43600000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	8282000	USD
CY2021Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	3388000	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	48119000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-11507000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-363316000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	4131490000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	14822000	USD
CY2021Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	2431000	USD
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	54011000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-206582000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-52833000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	3938477000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	3110981000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	13264000	USD
CY2020Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	13547000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	28731000	USD
CY2020Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	139053000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-34043000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-157833000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	2808500000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	176260000	USD
CY2020Q2	jazz	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature Repurchase AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeatureRepurchase	-12069000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4440000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	6547000	USD
CY2020Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1116000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	30599000	USD
CY2020Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	7484000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	21327000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	114801000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	3141805000	USD
CY2020Q3	jazz	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature Repurchase AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeatureRepurchase	-444000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	10088000	USD
CY2020Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1097000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	30307000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	48308000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	148234000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	3377201000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-294317000	USD
	us-gaap	Net Income Loss NetIncomeLoss	105202000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	368476000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	192505000	USD
	jazz	Inventory Step Up Value Adjustment InventoryStepUpValueAdjustment	148637000	USD
	jazz	Inventory Step Up Value Adjustment InventoryStepUpValueAdjustment	0	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	135887000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	89614000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	96593000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-120909000	USD
	jazz	Noncash Interest Expense NoncashInterestExpense	66055000	USD
	jazz	Noncash Interest Expense NoncashInterestExpense	45702000	USD
	us-gaap	Depreciation Depreciation	19387000	USD
	us-gaap	Depreciation Depreciation	14076000	USD
	jazz	Provision For Losses On Accounts Receivable And Inventory ProvisionForLossesOnAccountsReceivableAndInventory	13444000	USD
	jazz	Provision For Losses On Accounts Receivable And Inventory ProvisionForLossesOnAccountsReceivableAndInventory	9148000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	136139000	USD
	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	0	USD
	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	215250000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-9622000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-12672000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	27956000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5004000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	33891000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	21861000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	34722000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	64902000	USD
	jazz	Increase Decrease In Operating Lease Assets IncreaseDecreaseInOperatingLeaseAssets	-12054000	USD
	jazz	Increase Decrease In Operating Lease Assets IncreaseDecreaseInOperatingLeaseAssets	-9730000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	1837000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-13941000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	19167000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	20645000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	93534000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	26510000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	9171000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	15089000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1608000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-3540000	USD
	jazz	Increase Decrease In Operating Lease Liabilities Noncurrent IncreaseDecreaseInOperatingLeaseLiabilitiesNoncurrent	-13423000	USD
	jazz	Increase Decrease In Operating Lease Liabilities Noncurrent IncreaseDecreaseInOperatingLeaseLiabilitiesNoncurrent	-9884000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	16479000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	33254000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	600752000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	713377000	USD
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	1095000000	USD
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	920000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	17674000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10889000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	17891000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	113000000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	26694000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	1661750000	USD
	jazz	Payment To Acquire Assets Net Of Cash Acquired PaymentToAcquireAssetsNetOfCashAcquired	6234792000	USD
	jazz	Payment To Acquire Assets Net Of Cash Acquired PaymentToAcquireAssetsNetOfCashAcquired	0	USD
	jazz	Paymentsto Acquire In Process Researchand Development Other Than Through Business Combination PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination	0	USD
	jazz	Paymentsto Acquire In Process Researchand Development Other Than Through Business Combination PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination	215250000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5202051000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1080889000	USD
	jazz	Proceeds From Issuance Of Term Loan ProceedsFromIssuanceOfTermLoan	3719930000	USD
	jazz	Proceeds From Issuance Of Term Loan ProceedsFromIssuanceOfTermLoan	0	USD
	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	1471533000	USD
	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	117111000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	34339000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	29603000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	15760000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	218812000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	356188000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	843028000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	25040000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	981381000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	500000000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	146537000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	500000000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4217131000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	472195000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1821000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-85000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-385989000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	104598000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1057769000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	637344000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	671780000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	741942000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:14pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures in the condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could differ materially from those estimates.</span></div>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:14pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Risk</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to concentrations of credit risk consist of cash, cash equivalents, investments and derivative contracts. Our investment policy permits investments in U.S. federal government and federal agency securities, corporate bonds or commercial paper issued by U.S. corporations, money market instruments, certain qualifying money market mutual funds, certain repurchase agreements, and tax-exempt obligations of U.S. states, agencies and municipalities and places restrictions on credit ratings, maturities, and concentration by type and issuer. We are exposed to credit risk in the event of a default by the financial institutions holding our cash, cash equivalents and investments to the extent recorded on the balance sheet.</span></div>We manage our foreign currency transaction risk and interest rate risk within specified guidelines through the use of derivatives. All of our derivative instruments are utilized for risk management purposes, and we do not use derivatives for speculative trading purposes.The counterparties to these contracts are large multinational commercial banks, and we believe the risk of nonperformance is not significant.We are also subject to credit risk from our accounts receivable related to our product sales. We monitor our exposure within accounts receivable and record a reserve against uncollectible accounts receivable as necessary. We extend credit to pharmaceutical wholesale distributors and specialty pharmaceutical distribution companies, primarily in the U.S., and to other international distributors and hospitals. Customer creditworthiness is monitored and collateral is not required. We monitor economic conditions in certain European countries which may result in variability of the timing of cash receipts and an increase in the average length of time that it takes to collect accounts receivable outstanding.We depend on single source suppliers for most of our products, product candidates and their active pharmaceutical ingredients, or APIs. With respect to our oxybate products, the API is manufactured for us by a single source supplier and the finished products are manufactured both by us in our facility in Athlone, Ireland and by our U.S.-based supplier.
CY2021Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	671780000	USD
CY2021Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2021Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	671780000	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	671780000	USD
CY2021Q3	us-gaap	Investments Investments	0	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	2132769000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	2132769000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1057769000	USD
CY2020Q4	us-gaap	Investments Investments	1075000000	USD
CY2021Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	100000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1700000	USD
CY2020Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	2100000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	9700000	USD
CY2021Q3	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	5000000	USD
CY2021Q3	us-gaap	Derivative Asset Fair Value Gross Asset Including Not Subject To Master Netting Arrangement DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement	1203000	USD
CY2021Q3	us-gaap	Derivative Liability Fair Value Gross Liability Including Not Subject To Master Netting Arrangement DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement	30493000	USD
CY2020Q4	us-gaap	Derivative Asset Fair Value Gross Asset Including Not Subject To Master Netting Arrangement DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement	11907000	USD
CY2020Q4	us-gaap	Derivative Liability Fair Value Gross Liability Including Not Subject To Master Netting Arrangement DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement	3625000	USD
CY2021Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	25084000	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	16003000	USD
CY2021Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1055931000	USD
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	45758000	USD
CY2021Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	56836000	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	33635000	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	1137851000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	95396000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	958303000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	947831000	USD
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-56587000	USD
CY2021Q3	us-gaap	Goodwill Goodwill	1849547000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8191353000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1063493000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7127860000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3395214000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1200163000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2195051000	USD
CY2021Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	8346072000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1063493000	USD
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7282579000	USD
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	3395214000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1200163000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2195051000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	156233000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	624931000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	624931000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	624931000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	624931000	USD
CY2021Q3	jazz	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	4471903000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7127860000	USD
CY2021Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	333602000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	195523000	USD
CY2021Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	78596000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	67588000	USD
CY2021Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	255006000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	127935000	USD
CY2021Q3	jazz	Deferred Tax Intercompany Profit Current DeferredTaxIntercompanyProfitCurrent	183833000	USD
CY2020Q4	jazz	Deferred Tax Intercompany Profit Current DeferredTaxIntercompanyProfitCurrent	114234000	USD
CY2021Q3	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	41265000	USD
CY2020Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	38257000	USD
CY2021Q3	us-gaap	Other Assets Current OtherAssetsCurrent	225098000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	152491000	USD
CY2021Q3	jazz	Accrued Rebates And Other Sales Deductions AccruedRebatesAndOtherSalesDeductions	207793000	USD
CY2020Q4	jazz	Accrued Rebates And Other Sales Deductions AccruedRebatesAndOtherSalesDeductions	127534000	USD
CY2021Q3	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	160581000	USD
CY2020Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	102601000	USD
CY2021Q3	jazz	Accrued Interest AccruedInterest	35102000	USD
CY2020Q4	jazz	Accrued Interest AccruedInterest	5722000	USD
CY2021Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	30493000	USD
CY2020Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	3625000	USD
CY2021Q3	jazz	Accrued Clinical Trial Liability AccruedClinicalTrialLiability	24731000	USD
CY2020Q4	jazz	Accrued Clinical Trial Liability AccruedClinicalTrialLiability	9108000	USD
CY2021Q3	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	19077000	USD
CY2020Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	15230000	USD
CY2021Q3	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	18372000	USD
CY2020Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	6742000	USD
CY2021Q3	jazz	Lease Liability Current LeaseLiabilityCurrent	17045000	USD
CY2020Q4	jazz	Lease Liability Current LeaseLiabilityCurrent	14457000	USD
CY2021Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	16424000	USD
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	6660000	USD
CY2021Q3	jazz	Sales Return Reserve SalesReturnReserve	11768000	USD
CY2020Q4	jazz	Sales Return Reserve SalesReturnReserve	18368000	USD
CY2021Q3	jazz	Accrued Inventory Related Liabilities AccruedInventoryRelatedLiabilities	8553000	USD
CY2020Q4	jazz	Accrued Inventory Related Liabilities AccruedInventoryRelatedLiabilities	9809000	USD
CY2021Q3	jazz	Accrued Construction In Progress AccruedConstructionInProgress	5031000	USD
CY2020Q4	jazz	Accrued Construction In Progress AccruedConstructionInProgress	1119000	USD
CY2021Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	48745000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	31757000	USD
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	603715000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	352732000	USD
CY2021Q3	us-gaap	Long Term Debt LongTermDebt	6278287000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	2094838000	USD
CY2021Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	31000000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	246322000	USD
CY2021Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	6247287000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1848516000	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	7750000	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	31000000	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	31000000	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	606000000	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	31000000	USD
CY2021Q3	jazz	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	5942958000	USD
CY2021Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	6649708000	USD
CY2021Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	6632000	USD
CY2020Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	5501000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	18782000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	16201000	USD
CY2021Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1712000	USD
CY2020Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	943000	USD
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	4566000	USD
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	2704000	USD
CY2021Q3	us-gaap	Sublease Income SubleaseIncome	0	USD
CY2020Q3	us-gaap	Sublease Income SubleaseIncome	0	USD
	us-gaap	Sublease Income SubleaseIncome	0	USD
	us-gaap	Sublease Income SubleaseIncome	224000	USD
CY2021Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	193000	USD
CY2020Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	0	USD
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	201000	USD
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	0	USD
CY2021Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	114000	USD
CY2020Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	USD
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	185000	USD
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	USD
CY2021Q3	us-gaap	Lease Cost LeaseCost	8651000	USD
CY2020Q3	us-gaap	Lease Cost LeaseCost	6444000	USD
	us-gaap	Lease Cost LeaseCost	23734000	USD
	us-gaap	Lease Cost LeaseCost	18681000	USD
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	89628000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	129169000	USD
CY2021Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	5853000	USD
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	0	USD
CY2021Q3	jazz	Operating Lease And Finance Lease Right Of Use Asset OperatingLeaseAndFinanceLeaseRightOfUseAsset	95481000	USD
CY2020Q4	jazz	Operating Lease And Finance Lease Right Of Use Asset OperatingLeaseAndFinanceLeaseRightOfUseAsset	129169000	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	16643000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14457000	USD
CY2021Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	402000	USD
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	0	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	89359000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	140035000	USD
CY2021Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6360000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
CY2021Q3	jazz	Operating And Finance Lease Liability OperatingAndFinanceLeaseLiability	112764000	USD
CY2020Q4	jazz	Operating And Finance Lease Liability OperatingAndFinanceLeaseLiability	154492000	USD
CY2021Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y8M12D
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y8M12D
CY2021Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P13Y1M6D
CY2021Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.052
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.053
CY2021Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.074
CY2020Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0
	us-gaap	Operating Lease Payments OperatingLeasePayments	19707000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	11404000	USD
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	433000	USD
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	0	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	211000	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	7703000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	533000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	650000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
	jazz	De Recognition Of Operating Lease Asset On Lease Assignment DeRecognitionOfOperatingLeaseAssetOnLeaseAssignment	56968000	USD
	jazz	De Recognition Of Operating Lease Asset On Lease Assignment DeRecognitionOfOperatingLeaseAssetOnLeaseAssignment	0	USD
	jazz	De Recognition Of Operating Lease Liability On Lease Assignment DeRecognitionOfOperatingLeaseLiabilityOnLeaseAssignment	68064000	USD
	jazz	De Recognition Of Operating Lease Liability On Lease Assignment DeRecognitionOfOperatingLeaseLiabilityOnLeaseAssignment	0	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	4059000	USD
CY2021Q3	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	250000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	20777000	USD
CY2021Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	873000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	19941000	USD
CY2021Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	870000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	20892000	USD
CY2021Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	870000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	14559000	USD
CY2021Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	870000	USD
CY2021Q3	jazz	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	47278000	USD
CY2021Q3	jazz	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	6967000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	127506000	USD
CY2021Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	10700000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	21504000	USD
CY2021Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	3938000	USD
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	106002000	USD
CY2021Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	6762000	USD
CY2021Q3	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	65700000	USD
	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	-265731000	USD
	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	-2566000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-263165000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-52833000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	148234000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-294317000	USD
	us-gaap	Net Income Loss NetIncomeLoss	105202000	USD
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61284000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55545000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59084000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55637000	shares
CY2021Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2020Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	691000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	660000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61284000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56236000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59084000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56297000	shares
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.86
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.67
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.98
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.89
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.86
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.64
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.98
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.87
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	838115000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	600888000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2197507000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1698050000	USD
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	838115000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	600888000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2197507000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1698050000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4861000	USD
	jazz	Contract With Customer Liability Increase Decrease For Governmental Grant ContractWithCustomerLiabilityIncreaseDecreaseForGovernmentalGrant	484000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2092000	USD
CY2021Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3253000	USD
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	53239000	USD
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	30356000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	135887000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	89614000	USD
CY2021Q3	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	10567000	USD
	jazz	Income Tax Examination Penalties And Interest Paid IncomeTaxExaminationPenaltiesAndInterestPaid	19700000	USD
CY2020Q3	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	3678000	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	25528000	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	10106000	USD
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	42672000	USD
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	26678000	USD
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	110359000	USD
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	79508000	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-18100000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	228600000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	19300000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	22800000	USD
	jazz	Uk Finance Act Change In Tax Rate Deferred Tax Liability Income Tax Expense Benefit UKFinanceActChangeInTaxRateDeferredTaxLiabilityIncomeTaxExpenseBenefit	250600000	USD

Files In Submission

Name	View Source	Status
0001232524-21-000061-index-headers.html	Edgar Link	pending
0001232524-21-000061-index.html	Edgar Link	pending
0001232524-21-000061.txt	Edgar Link	pending
0001232524-21-000061-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
jazz-20210930.htm	Edgar Link	pending
jazz-20210930.xsd	Edgar Link	pending
jazz-20210930_cal.xml	Edgar Link	unprocessable
jazz-20210930_def.xml	Edgar Link	unprocessable
jazz-20210930_htm.xml	Edgar Link	completed
jazz-20210930_lab.xml	Edgar Link	unprocessable
jazz-20210930_pre.xml	Edgar Link	unprocessable
jazzq32021ex101.htm	Edgar Link	pending
jazzq32021ex311.htm	Edgar Link	pending
jazzq32021ex312.htm	Edgar Link	pending
jazzq32021ex321.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$JAZZ
Jazz Pharmaceuticals PLC Stock $jazz

2021 Q4 Form 10-Q Financial Statement

#000123252421000061 Filed on November 09, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JAZZ Jazz Pharmaceuticals PLC Stock $jazz

2021 Q4 Form 10-Q Financial Statement

#000123252421000061 Filed on November 09, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JAZZ
Jazz Pharmaceuticals PLC Stock $jazz